New Zealand markets closed

ACADIA Pharmaceuticals Inc. (ACAD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
18.47+0.26 (+1.46%)
As of 03:18PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close18.20
Open18.20
Bid18.44 x 200
Ask18.49 x 200
Day's range18.05 - 18.49
52-week range17.56 - 33.99
Volume586,829
Avg. volume1,870,432
Market cap3.043B
Beta (5Y monthly)0.40
PE ratio (TTM)N/A
EPS (TTM)-0.37
Earnings date06 May 2024 - 10 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est29.54
  • GuruFocus.com

    ACADIA Pharmaceuticals Inc CEO Stephen Davis Sells 17,714 Shares

    Stephen Davis, the CEO of ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), has sold 17,714 shares of the company on March 27, 2024, according to a recent SEC filing.

  • Business Wire

    Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    SAN DIEGO, March 15, 2024--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that on March 11, 2024, the Compensation Committee of Acadia’s Board of Directors (the "Committee") granted inducement awards consisting of non-qualified stock options to purchase 8,904 shares of common stock and 5,461 restricted stock units ("RSUs") to three new employees under Acadia’s 2023 Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees’ employme

  • Business Wire

    Acadia Pharmaceuticals to Participate in the UBS Virtual CNS Day

    SAN DIEGO, March 13, 2024--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate in the UBS Virtual CNS Day on Monday, March 18, 2024 at 2:00 p.m. Eastern Time.